·5 min read·evidence
What the second year on tirzepatide actually looks like
Almost all the public conversation about tirzepatide is about the first six months. The trial data, the dramatic before-and-afters, the side-effects window. The second year is where the harder questions live: maintenance dose, plateau, lean mass, and the question nobody asks until they're in it.